Aysu Bicer
30 September 2026•Update: 30 September 2026
More than 44,000 people have filed legal objections to their personal health data being shared with, stored in, or used by the Palantir-powered Federated Data Platform (FDP), amid growing controversy about the company’s role in Britain’s National Health Service (NHS), according to a report by the Guardian newspaper.
The coordinated campaign uses rights under data protection laws, requiring the NHS to stop using the data unless it can provide a “compelling reason” to continue.
The campaign comes as hundreds of thousands of people signed petitions calling for the government to cancel a £330 million deal with the US technology company.
Campaigners have also raised concerns about Palantir’s work for the Israeli military and US Immigration and Customs Enforcement (ICE) under US President Donald Trump.
Two House of Commons select committees have urged the Labour government to exercise a break clause in the seven-year NHS contract, which takes effect in February.
“I am a believer in the NHS having really good data on their patients, but I want it to be something you can really trust to be used for the right purposes. I am not happy about Palantir’s involvement with the IDF in Gaza and ICE in America,” said David Murray, a retired IBM systems engineer who filed an objection.
Palantir said its technology is helping improve NHS services.
The company said trusts using the FDP recorded 117,000 additional operations, a 14.3% reduction in discharge delays for long-stay patients and a 5.6% improvement in patients receiving cancer results within 28 days.
Palantir executive Louis Mosley has dismissed criticism of the company’s NHS work as “Palantir derangement syndrome.”